Evaluation of MR markers that predict survival in patients with newly diagnosed GBM prior to adjuvant therapy
Saraswathy S, Crawford FW, Lamborn KR, Pirzkall A, Chang S, Cha S, Nelson SJ. Evaluation of MR markers that predict survival in patients with newly diagnosed GBM prior to adjuvant therapy. Journal Of Neuro-Oncology 2008, 91: 69-81. PMID: 18810326, PMCID: PMC3022437, DOI: 10.1007/s11060-008-9685-3.Peer-Reviewed Original ResearchConceptsGlioblastoma multiformeRadiation therapyExternal beam radiation therapyLethal primary brain tumorProportional hazards analysisSurvival of patientsPrimary brain tumorsSpecific treatment protocolsBeam radiation therapyAdjuvant radiationAdjuvant therapySurgical resectionLesion burdenMR parametersPoor outcomeAnatomic lesionsPoor survivalScanner field strengthTreatment protocolStudy populationFocal therapyHigh riskBrain tumorsPatientsPredictive value